Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Raw Materials (2022 - 2026)

HeartSciences filings provide 5 years of Raw Materials readings, the most recent being $375902.0 for Q1 2026.

  • On a quarterly basis, Raw Materials rose 16.38% to $375902.0 in Q1 2026 year-over-year; TTM through Jan 2026 was $375902.0, a 16.38% increase, with the full-year FY2025 number at $347036.0, up 7.44% from a year prior.
  • Raw Materials hit $375902.0 in Q1 2026 for HeartSciences, up from $322996.0 in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $375902.0 in Q1 2026 to a low of $322996.0 in Q2 2023.
  • Median Raw Materials over the past 5 years was $322996.0 (2023), compared with a mean of $337047.4.
  • Biggest five-year swings in Raw Materials: fell 10.27% in 2023 and later increased 16.38% in 2026.
  • HeartSciences' Raw Materials stood at $359965.0 in 2022, then fell by 10.27% to $322996.0 in 2023, then changed by 0.0% to $322996.0 in 2024, then changed by 0.0% to $322996.0 in 2025, then increased by 16.38% to $375902.0 in 2026.
  • The last three reported values for Raw Materials were $375902.0 (Q1 2026), $322996.0 (Q4 2025), and $322996.0 (Q3 2025) per Business Quant data.